Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
08/2005
08/04/2005WO2005071082A1 Antisense oligonucleotide having anticancerous activity
08/04/2005WO2005070469A1 Methods of treating mesothelioma using an antisense oligonucleotide to thymidylate synthase
08/04/2005WO2005070467A2 Method of protecting sensitive molecules from a photopolymerizing environment
08/04/2005WO2005070466A2 Liposome composition for delivery of therapeutic agents
08/04/2005WO2005070459A1 Method of continuing expression of vector repeatedly administered
08/04/2005WO2005070011A2 Improved modalities for the treatment of degenerative diseases of the retina
08/04/2005WO2005069994A2 Folate conjugates and complexes
08/04/2005WO2005069987A2 Amplifying interfering rna (rnai) expression and effects
08/04/2005WO2005069975A2 Lysyl oxidase-like 1 (loxl1) and elastogenesis
08/04/2005WO2005069880A2 Modulation of line-1 reverse transcriptase
08/04/2005WO2005056020A3 Nf-kb oligonucleotide decoy molecules
08/04/2005WO2005049793A3 Methods and compositions for combinatorial approaches to cancer gene therapy
08/04/2005WO2005048930A3 Surfactant-based gel as an injectable, sustained drug delivery vehicle
08/04/2005WO2005023994A3 Modified oligonucleotides for telomerase inhibition
08/04/2005WO2005003323A3 Use of calcium binding proteins to improve cardiac contractile function
08/04/2005WO2004108072A3 Delivery of immune response modifier compounds using metal-containing particulate support materials
08/04/2005WO2004089283A3 Compositions and methods for treating viral infections
08/04/2005WO2004080273A3 Compositions and methods for diagnosing and treating prostate cancer
08/04/2005WO2004064782A3 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides
08/04/2005WO2004046324A3 Allele-targeted rna interference
08/04/2005WO2004016726A9 Methods and compositions for extending the life span and increasing the stress resistance of cells and organisms
08/04/2005WO2003000009A3 Stimulation of vascularization with vegf-b
08/04/2005US20050172352 Using presence of allelic mutation in protein kinase c gene as diagnostic indication of heart disease
08/04/2005US20050172346 Method for treating a condition with a SOCS-3 promoter linked to a polynucleotide encoding SOCS-3
08/04/2005US20050171338 Mammalian tribbles signaling pathways and methods and reagents related thereto
08/04/2005US20050171335 Novel antimicrobial peptide and use thereof
08/04/2005US20050171048 Nuclease activity resistance; mixed sequence oligonucleotides containing purine or pyrimidine base in beta anomeric configuration; drug delivery agents; targeting specific DNA and/or RNA sequences
08/04/2005US20050171047 Immunostimulatory nucleic acid molecules
08/04/2005US20050171044 Oligonucleotide compound and method for treating nidovirus infections
08/04/2005US20050171043 Methods and compositions for modulating mitochondrial aldehyde dehydrogenase-2
08/04/2005US20050171041 Identifying drug targets; assaying for expression of candidate ribonucleic acid in RNAi pathway molecule and svRNA
08/04/2005US20050171039 RNA interference mediated inhibition of vascular endothelial growth factor and vascular endothelial growth factor receptor gene expression using short interfering nucleic acid (siNA)
08/04/2005US20050171016 Thrombospondin-2 and uses thereof
08/04/2005US20050170509 Preparation of stable formulations of lipid-nucleic acid complexes for efficient in vivo delivery
08/04/2005US20050170508 For transfecting nucleic acids in vivo or ex vivo; vesicle forming lipid and hydrophilic polymer; gene therapy
08/04/2005US20050170507 Novel lentiviral packaging cells
08/04/2005US20050170504 Method for transfer of molecular substances with prokaryontic nucleic acid-binding proteins
08/04/2005US20050170500 Methods for identifying risk of melanoma and treatments thereof
08/04/2005US20050170434 Modulators of lymphocyte activation, mkk3b compositions and methods of use
08/04/2005US20050170384 Expression vector comprising nucleotide sequences coding protein with sequence similarities to chordin proteins for use as tool in identifying modulator for treatment and prevention of infection and metabolic disorders
08/04/2005US20050170377 Anticode oligomer for prevention and treatment of cell proliferative disorders; antitumor, antisense, antiproliferative agents
08/04/2005US20050170366 Novel hair keratin-associated proteins
08/04/2005US20050170355 Mixture of a nucleic acid and a chitosan with branching groups attached to the amino group, selected from alkyl groups with 2 or more carbon atoms, monosaccharides, oligosaccharides or polysaccharides; gene therapy, genetic vaccines, antisense therapy, anticarcinogenic agents, autoimmune diseases
08/04/2005US20050170348 Nuclear-envelope and nuclear-lamina binding chimeras for modulating gene expression
08/04/2005US20050170344 Chds as modifiers of the p53 pathway and methods of use
08/04/2005US20050169995 Modulation of gastrointestinal epithelium proliferation through the Wnt signaling pathway
08/04/2005US20050169921 administering an anti-C5 antibody for treating paroxysmal nocturnal hemoglobinuria blood disorder; reduction in lactate dehydrogenase; biodrug for hemoglobinuria, anemia, hemoglobinemia, dysphagia, fatigue, nitric oxide (NO) deficiency, erectile dysfunction, recurrent abdominal pain and thrombosis
08/04/2005US20050169917 Orphanin FQ receptor
08/04/2005US20050169913 Administering a monoclonal antibody or enzyme inhibitor of prothrombinase; therapeutic treatment of bacterial and viral infections, allograft and xenograft rejection, cancer, glomerulonephritis, gastrointestinal disorders and fetal loss; inhibiting gene expression of prothrombinase
08/04/2005US20050169899 Exploiting endogenous import and export mechanisms of ribonucleic acid trafficking which utilize nuclear targeting peptides containing nonclassical nuclear localization signals
08/04/2005US20050169892 Adeno-associated virus materials and methods
08/04/2005US20050169891 Tissue tropism of a virus capsid, of protein fragments from different viruses, adenovirus of subgroup C or subgroup B
08/04/2005US20050169890 Recombinant vector; overexpresses an adenovirus death protein (ADP), is replication-restricted to neoplastic cells expressing telomerase
08/04/2005US20050169889 Immunogenic agent therapy using plasmapheresis or exchange transfusion
08/04/2005CA2595573A1 Methods of treating mesothelioma using an antisense oligonucleotide to thymidylate synthase
08/04/2005CA2555370A1 Improved modalities for the treatment of degenerative diseases of the retina
08/04/2005CA2554075A1 Method of protecting sensitive molecules from a photopolymerizing environment
08/04/2005CA2553541A1 Chimpanzee adenovirus vaccine carriers
08/04/2005CA2553426A1 Liposome composition for delivery of therapeutic agents
08/04/2005CA2553265A1 Modulation of line-1 reverse transcriptase
08/04/2005CA2553221A1 Folate conjugates and complexes
08/03/2005EP1559795A2 Neisseria genomic sequences and methods of their use
08/03/2005EP1559785A1 Oligo- or polynucleotides for achieving RNA interference in mammalian cells
08/03/2005EP1559726A2 Growth differentiation factor-10
08/03/2005EP1558749A2 Atypical protein kinase c isoforms in disorders of the nervous system and cancer
08/03/2005EP1558737A1 Gene families associated with cancers
08/03/2005EP1558282A2 Anti-cancer and anti-infectious disease compositions and methods for using same
08/03/2005EP1558086A2 Cell targeting methods and compositions
08/03/2005EP1418937A4 Enhancing organ maturity in neonates and predicting their duration of intensive care
08/03/2005EP1267899B1 Ssa inactivated salmonella vaccines
08/03/2005EP0896620B1 Modified nuclear glucocorticoid receptor, fusion protein, and dna fragments coding for said receptor and said fusion protein
08/03/2005EP0815231B1 Use of neuronal apoptosis inhibitor protein (naip)
08/03/2005EP0755259B1 CHIMERIC INFECTIOUS BURSAL DISEASE VIRUS cDNA CLONES, EXPRESSION PRODUCTS AND VACCINES BASED THEREON
08/03/2005EP0742834B2 Method of preparing a viral vector of at least 20kb by intermolecular recombination in a procaryotic cell
08/03/2005EP0702722B1 Plasmids suitable for gene therapy
08/03/2005CN1650033A Genomic screen for epigenetically silenced genes associated with cancer
08/03/2005CN1650021A Stable adenoviral vectors and methods for propagation thereof
08/03/2005CN1650020A Means and methods for the production of adenovirus vectors
08/03/2005CN1650015A DNA vaccines encoding CEA and a CD40 ligand and methods of use thereof
08/03/2005CN1650011A Methods and compositions for treating neoplasms by ERBB3
08/03/2005CN1650010A Method for inhibiting the expression of a target gene and medicine for treating tumor disease
08/03/2005CN1649895A Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
08/03/2005CN1649623A Specific antibodies to amyloid beta peptide, pharmaceutical compositions and methods of use thereof
08/03/2005CN1649622A DNA vaccine against proliferating endothelial cells and methods of use thereof
08/03/2005CN1649618A Methods
08/03/2005CN1649496A Composition and method to alter lean body mass and bone properties in a subject
08/03/2005CN1648250A Smal linterference ribonucleic acid sequence of hepatitis B virus gene and preparing method
08/03/2005CN1647824A Virus gene recombining technology and grafting therapeutic method
08/03/2005CN1213068C Improvments in or relating to immune responses to HIV
08/02/2005US6924415 Identified as a target for therapeutic intervention due to its role in molecular events that lead to or contribute to cardiac hypertrophy and/or dilated cardiomyopathy
08/02/2005US6924367 Method of modulating tissue growth using Frzb Protein
08/02/2005US6924356 Human protein HHEPU32
08/02/2005US6924266 NTP-peptides and method for removal of tumors
08/02/2005US6924146 Method of constructing vectors for homologous recombination directed mutagenesis
08/02/2005US6924144 Method and means for producing high titer, safe, recombinant lentivirus vectors
08/02/2005US6924141 Inducing the effects of promoted signal transduction with protein and lithium chloride or mimicking via administration of agent that inhibits either catenin phosphorylation or kinase
08/02/2005US6924137 virus is propagated in culture media at a cultivation temperature below 37 degrees C., wherein the chordopoxvirus is selected from Avipoxvirus and modified vaccinia virus Ankara
08/02/2005US6924128 Packaging cell lines for generation of high titers of recombinant AAV vectors
08/02/2005US6924123 Transducting, dividing cells; gene expression; gene therapy
08/02/2005US6924117 Human RRP sequences and methods of use
1 ... 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 ... 870